Simparica chewable tablets for dogs
SIMPARICA 5 mg (chewable tablets for dogs). Reg. No.: G4317 (Act 36/1947). Each chewable tablet contains 5 mg sarolaner.
SIMPARICA 10 mg (chewable tablets for dogs). Reg. No.: G4322 (Act 36/1947). Each chewable tablet contains 10 mg sarolaner.
SIMPARICA 20 mg (chewable tablets for dogs). Reg. No.: G4318 (Act 36/1947). Each chewable tablet contains 20 mg sarolaner.
SIMPARICA 40 mg (chewable tablets for dogs). Reg. No.: G4319 (Act 36/1947). Each chewable tablet contains 40 mg sarolaner.
SIMPARICA 80 mg (chewable tablets for dogs). Reg. No: G4320 (Act 36/1947). Each chewable tablet contains 80 mg sarolaner
SIMPARICA 120 mg (chewable tablets for dogs). Reg. No.: G4321 (Act 36/1947). Each chewable tablet contains 120 mg sarolaner
Expand All
-
- For the treatment of tick infestations on dogs.
- The product has immediate and persistent tick killing activity for at least 5 weeks.
- For the treatment and prevention of flea infestations on dogs. The product has immediate and persistent flea killing activity against new infestations for 5 weeks. The product may be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD). Consult your veterinarian.
- The product kills fleas before they can lay eggs.
- Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. For fleas, the onset of effect is within 8 hours of attachment. For ticks, the onset of effect is within 12 hours of attachment.
-
Active substance: Sarolaner 5 mg; 10 mg; 20 mg; 40 mg; 80 mg and 120 mg per chewable tablet.
Mottled brown coloured, square shaped chewable tablets with rounded edges.
The number embossed on one side refers to the different strengths (mg) of the tablets: “5”, “10”,”20”, “40”, “80” or “120”.
-
- Do not treat puppies less than 8 weeks of age and/or dogs weighing less than 1.7 kg.
- Do not treat pregnant and lactating dogs.
- IMPORTANT: Consult your veterinarian as the safety of this product has not been established during pregnancy and lactation. Use only as directed by your veterinarian according to a benefit/risk assessment by the responsible veterinarian.
- Only one chewable tablet at a time should be removed from the blister to prevent children from accessing the product. The blister should be returned into the carton and kept out of reach of children, uninformed persons and animals.
- Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensure as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
-
- Wash hands after handling the product.
- Dispose of any containers, disposable equipment and any other waste after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008)
-
For oral use.
SIMPARICA is a chewable and palatable tablet readily consumed by dogs when offered by the owner. If the tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth. The tablets should not be divided.
Tablets can be administered with or without food.
The product should be administered at a dose of 2–4 mg/kg body weight in accordance with the following table:
Body weight
(kg) Tablet strength
(mg sarolaner) Number of tablets to be administered
1.3–2.5 5 One
>2.5–5 10 One
>5–10 20 One
>10–20 40 One
>20 –40 80 One
>40–60 120 One
>60.0 Appropriate combination of tablets
-
Store at or below 30°C in a cool, dry place.
DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.
Learn more -
http://www.simparicafordogs.co.za/
MM-37235
